{"id":625153,"title":"Canada Gazette Part I – Biologics, Radio-pharmaceuticals & Genetic Therapies - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T09:00:26.494000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/legislation-guidelines/gazette.html","snippet":"Canada Gazette Part I – Biologics, Radio-pharmaceuticals & Genetic Therapies The following proposed regulatory amendments and Regulatory Impact Analysis Statement (RIAS) were recently pre-published in the Canada Gazette Part I for public consultation. Readers are invited to…","rawSnapshotUrl":"/api/snapshots/raw/625153","browseUrl":"https://replay.healtharchive.ca/job-6/20260227090026/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/legislation-guidelines/gazette.html#ha_snapshot=625153","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}